Coronary atherosclerosis Clinical Trials

4 recruiting

Coronary atherosclerosis Trials at a Glance

10 actively recruiting trials for coronary atherosclerosis are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Aalborg, Aarhus, and Baltimore. Lead sponsors running coronary atherosclerosis studies include ECRI bv, Federico II University, and Aarhus University Hospital.

Browse coronary atherosclerosis trials by phase

Treatments under study

About Coronary atherosclerosis Clinical Trials

Looking for clinical trials for Coronary atherosclerosis? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Coronary atherosclerosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Coronary atherosclerosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 3

Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction

Coronary Artery DiseaseAcute Myocardial Infarction (AMI)Coronary Atherosclerosis of Native Coronary Artery
ECRI bv332 enrolled1 locationNCT07276282
Recruiting
Not Applicable

PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]

AtherosclerosisCoronary Artery DiseaseCoronary Atherosclerosis of Native Coronary Artery
Johns Hopkins University33 enrolled1 locationNCT05994014
Recruiting

INOCA-NA a Local Prospective Registry

Coronary Microvascular Dysfunction (CMD)Non-Obstructive Coronary AtherosclerosisMicrocirculatory Status+1 more
Federico II University250 enrolled1 locationNCT06588244
Recruiting
Not Applicable

VIsualization of Coronary Artery Disease for Modification of RISK Factors

Coronary Artery DiseaseNon-Obstructive Coronary Atherosclerosis
Aarhus University Hospital273 enrolled5 locationsNCT06413641
Recruiting
Not Applicable

Routine Versus As-Needed Stress Testing in Asymptomatic Patients With High-Risk Coronary Calcium

Coronary Atherosclerosis Due to Calcified Coronary Lesion
Samsung Medical Center3,000 enrolled1 locationNCT05796739
Recruiting

Cardiovascular Risk Stratification on the Basis of Surface Enhanced Raman Spectroscopy

Coronary Atherosclerosis of Native Coronary Artery
Samara State Medical University220 enrolled1 locationNCT06399328
Recruiting

Coexistence of Cerebral and Coronary Atherosclerosis in Acute Ischemic Cerebrovascular Disease Patients Registry

Coexistence of Cerebral and Coronary AtherosclerosisAcute Ischemic Cerebrovascular Disease
Xuanwu Hospital, Beijing500 enrolled1 locationNCT03788512
Recruiting

The ARISTOCRAT Registry- The Australian natural history of pericoronary adipose tissue attenuation, radiomics and plaque by computed tomographic angiography

Coronary atherosclerosis
Monash Cardiovascular Research Centre, Victorian Heart Institute and Monash University300 enrolled10 locationsACTRN12621001018808
Recruiting

Myocardial Ischemia Without Obstructive Coronary Stenoses

Myocardial IschemiaMicrovascular Coronary Artery DiseaseNon-Obstructive Coronary Atherosclerosis+2 more
Hospital San Carlos, Madrid600 enrolled1 locationNCT04827498
Recruiting
Phase 2Phase 3

Do stAtins faVourably modify atherosclerotIc plaque in patients with differeNt levels of polygenic Cardiovascular (CV) rIsk?

Coronary atherosclerosisPolygenic risk
Monash University600 enrolled6 locationsACTRN12620001166965